Point‐of‐care viral load monitoring: outcomes from a decentralized HIV programme in Malawi

Routinely monitoring the HIV viral load (VL) of people living with HIV (PLHIV) on anti‐retroviral therapy (ART) facilitates intensive adherence counselling and faster ART regimen switch when treatment failure is indicated. Yet standard VL‐testing in centralized laboratories can be time‐intensive and logistically difficult in low‐resource settings. This paper evaluates the outcomes of the first four years of routine VL‐monitoring using Point‐of‐Care technology, implemented by Médecins Sans Frontières (MSF) in rural clinics in Malawi.

[1]  A. Phillips,et al.  Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure , 2019, AIDS.

[2]  A. Jahn,et al.  The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings , 2019, PLoS medicine.

[3]  Chunfu Yang,et al.  Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second‐line switches in Swaziland , 2018, Journal of the International AIDS Society.

[4]  M. Peeters,et al.  The fourth HIV epidemic. , 2018, The Lancet. Infectious diseases.

[5]  M. Mwau,et al.  Scale-up of Kenya’s national HIV viral load program: Findings and lessons learned , 2018, PloS one.

[6]  MaartensGary,et al.  Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps , 2017 .

[7]  G. Maartens,et al.  Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps , 2017, AIDS research and human retroviruses.

[8]  Bactrin M Killingo,et al.  Community‐driven demand creation for the use of routine viral load testing: a model to scale up routine viral load testing , 2017, Journal of the International AIDS Society.

[9]  Zachary Katz,et al.  Scaling up HIV viral load – lessons from the large‐scale implementation of HIV early infant diagnosis and CD4 testing , 2017, Journal of the International AIDS Society.

[10]  T. Klimkait,et al.  When patients fail UNAIDS’ last 90 - the “failure cascade” beyond 90-90-90 in rural Lesotho, Southern Africa: a prospective cohort study , 2017, Journal of the International AIDS Society.

[11]  T. Decroo,et al.  Journey towards universal viral load monitoring in Maputo, Mozambique: many gaps, but encouraging signs , 2017, International health.

[12]  Helen H. Lee,et al.  Performance of the SAMBA I and II HIV-1 Semi-Q Tests for viral load monitoring at the point-of-care. , 2017, Journal of virological methods.

[13]  R. Hoffman,et al.  Supporting Quality Data Systems: Lessons Learned from Early Implementation of Routine Viral Load Monitoring at a Large Clinic in Lilongwe, Malawi. , 2017, Journal of clinical research in HIV AIDS and prevention.

[14]  J. Nkengasong,et al.  Specimen origin, type and testing laboratory are linked to longer turnaround times for HIV viral load testing in Malawi , 2017, PloS one.

[15]  S. Luchters,et al.  Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review , 2017, AIDS Research and Therapy.

[16]  M. Fox,et al.  Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa , 2016, PloS one.

[17]  K. Bonner,et al.  Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  M. Weinberger,et al.  On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings , 2016, AIDS care.

[19]  N. Ford,et al.  Closer to 90–90–90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study , 2016, Journal of the International AIDS Society.

[20]  Jeffrey W. Eaton,et al.  Sustainable HIV treatment in Africa through viral-load-informed differentiated care , 2015, Nature.

[21]  M. Mwasekaga,et al.  Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries. , 2015, MMWR. Morbidity and mortality weekly report.

[22]  M. Egger,et al.  Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. , 2015, The lancet. HIV.

[23]  B. Kerschberger,et al.  Viral load monitoring: how do HIV-positive patients interpret and understand their results? , 2015 .

[24]  M. Weinberger,et al.  Dried Blood Spots for Viral Load Monitoring in Malawi: Feasible and Effective , 2015, PloS one.

[25]  D. Boeras,et al.  Monitoring the Quality of HIV-1 Viral Load Testing through a Proficiency Testing Program Using Dried Tube Specimens in Resource-Limited Settings , 2015, Journal of Clinical Microbiology.

[26]  S. Agwale,et al.  HIV point-of-care diagnostics: meeting the special needs of sub-Saharan Africa. , 2014, Journal of infection in developing countries.

[27]  Lesley E Scott,et al.  Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions , 2014, BMC Medicine.

[28]  J. van Griensven,et al.  Impact and Programmatic Implications of Routine Viral Load Monitoring in Swaziland , 2014, Journal of acquired immune deficiency syndromes.

[29]  Megan McGuire,et al.  SAMBA HIV Semiquantitative Test, a New Point-of-Care Viral-Load-Monitoring Assay for Resource-Limited Settings , 2014, Journal of Clinical Microbiology.

[30]  I. Hewlett,et al.  Point of Care Technologies for HIV , 2014, AIDS research and treatment.

[31]  A. Calmy,et al.  Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa — A Systematic Review and Meta-Analysis , 2013, PloS one.

[32]  M. Peeters,et al.  Field Evaluation of Dried Blood Spots for Routine HIV-1 Viral Load and Drug Resistance Monitoring in Patients Receiving Antiretroviral Therapy in Africa and Asia , 2013, Journal of Clinical Microbiology.

[33]  W. Preiser,et al.  Pooled HIV-1 Viral Load Testing Using Dried Blood Spots to Reduce the Cost of Monitoring Antiretroviral Treatment in a Resource-Limited Setting , 2013, Journal of acquired immune deficiency syndromes.

[34]  N. Ford,et al.  Viral Load Monitoring as a Tool to Reinforce Adherence: A Systematic Review , 2013, Journal of acquired immune deficiency syndromes.

[35]  A. Phillips,et al.  Outcomes Following Virological Failure and Predictors of Switching to Second-line Antiretroviral Therapy in a South African Treatment Program , 2012, Journal of acquired immune deficiency syndromes.

[36]  L. Laursen.  Point-of-care tests poised to alter course of HIV treatment , 2012, Nature Medicine.

[37]  Marco Schito,et al.  Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. , 2012, The Journal of infectious diseases.

[38]  N. Ford,et al.  Challenges and opportunities for the implementation of virological testing in resource-limited settings , 2012, Journal of the International AIDS Society.

[39]  Beth Chaplin,et al.  Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  E. Szumilin,et al.  Benefit of viral load testing for confirmation of immunological failure in HIV patients treated in rural Malawi , 2011, Tropical medicine & international health : TM & IH.

[41]  B. Chi,et al.  Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa , 2011, AIDS.

[42]  T. F. Rinke de Wit,et al.  Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa , 2011, Journal of acquired immune deficiency syndromes.

[43]  R. Haubrich,et al.  Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  D. Bachani,et al.  Evaluating Patients for Second-Line Antiretroviral Therapy in India: The Role of Targeted Viral Load Testing , 2010, Journal of acquired immune deficiency syndromes.

[45]  Praphan Phanuphak,et al.  Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia , 2010, PloS one.

[46]  A. Calmy,et al.  Patient needs and point-of-care requirements for HIV load testing in resource-limited settings. , 2010, The Journal of infectious diseases.

[47]  Helen H. Lee,et al.  Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing. , 2010, The Journal of infectious diseases.

[48]  Wendy S Stevens,et al.  Challenges in implementing HIV load testing in South Africa. , 2010, The Journal of infectious diseases.

[49]  N. Ford,et al.  HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[50]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[51]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[52]  A. Phillips,et al.  Simplifying switch to second-line ART: Predicted effect of defining failure of first-line efavirenz-based regimens in sub-Saharan Africa by a single viral load more than 1000 copies/ml. , 2019, AIDS.

[53]  P. Drain,et al.  Point-of-care viral load testing and differentiated HIV care. , 2018, The lancet. HIV.

[54]  N. Ford,et al.  Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring. , 2017, The Lancet. Infectious diseases.

[55]  M. Egger,et al.  Monitoring and Switching of First-line Antiretroviral Therapy in sub-Saharan Africa: Collaborative Analysis of Adult Treatment Cohorts , 2015 .

[56]  N. Ford,et al.  HIV viral load monitoring in resource-limited regions: optional or necessary? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  L. Hazlehurst,et al.  Drug Resistance , 2004 .

[58]  Z. Rosenberg,et al.  Microbicides urgently needed: statement by IPM CEO, Zeda Rosenberg, on new AIDS statistics. Joint United Nations Programme on HIV/AIDS (UNAIDS) releases the 2004 AIDS epidemic update. , 2004 .